In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...

In today's ACT Brief, we explore how Bayesian methods are reshaping FDA interactions and trial design, quality tolerance limits are becoming operational guardrails in risk-based quality management, ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

Many engineering challenges come down to the same headache—too many knobs to turn and too few chances to test them. Whether tuning a power grid or designing a safer vehicle, each evaluation can be ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Japan is an archipelago with diverse climate zones and complex topography that is prone to heavy rain and flooding. Add the ...

The updated timing reflects ongoing FDA feedback to incorporate complete 12-month mortality data from the Tigris study into the PMA submission, as well as the completion of certain non-clinical module ...

People who lose their visual imagination after a stroke share damage to a single neural circuit. A new analysis maps these ...

This study provides important insights into how working memory shapes perceptual decisions, using a dual-task design, continuous mouse tracking, and hierarchical Bayesian modeling. By dissociating ...